Wen-Bo Zhou
Overview
Explore the profile of Wen-Bo Zhou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
129
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wu Y, Li P, Huang Z, Liu J, Yang B, Zhou W, et al.
Ther Adv Infect Dis
. 2024 Apr;
11:20499361241248058.
PMID: 38681967
Background: Urosepsis is a common disease in urology, which is characterized by high treatment costs and high mortality. In the treatment of sepsis, anti-infection therapy is the most important means....
2.
Cai X, Chen Y, Zhang X, Wang Y, Zhou W, Zhang C, et al.
Front Pharmacol
. 2022 Oct;
13:1019411.
PMID: 36313312
This study aims to characterize the population pharmacokinetics of polymyxin B in lung transplant recipients and optimize its dosage regimens. This prospective study involved carbapenem-resistant organisms-infected patients treated with polymyxin...
3.
Yuan Q, Xiao S, Farouk O, Du Y, Sheybani F, Tan Q, et al.
Mil Med Res
. 2022 Aug;
9(1):47.
PMID: 35999646
No abstract available.
4.
Yuan Q, Xiao S, Farouk O, Du Y, Sheybani F, Tan Q, et al.
Mil Med Res
. 2022 Apr;
9(1):20.
PMID: 35473758
Granulomatous lobular mastitis (GLM) is a rare and chronic benign inflammatory disease of the breast. Difficulties exist in the management of GLM for many front-line surgeons and medical specialists who...
5.
Wu L, Zhou W, Zhou J, Wei Y, Wang H, Liu X, et al.
Oncol Lett
. 2020 Jul;
20(2):1432-1440.
PMID: 32724386
Circulating exosomal microRNAs (ex-miRNAs) are reflective of the characteristics of the tumor and are valuable biomarkers in different types of tumor. In addition, miRNAs serve important roles in tumor progression...
6.
Wu L, Wei Y, Zhou W, Zhang Y, Chen Q, Liu M, et al.
Oncol Rep
. 2019 Jun;
42(1):115-130.
PMID: 31180554
Borax is a boron compound that is becoming widely recognized for its biological effects, including lipid peroxidation, cytotoxicity, genotoxicity, antioxidant activity and potential therapeutic benefits. However, it remains unknown whether...
7.
Zhou W, Miao Z, Zhang B, Long W, Zheng F, Kong J, et al.
Neural Regen Res
. 2019 Jan;
14(4):613-620.
PMID: 30632501
Studies have shown that the natural flavonoid luteolin has neurotrophic activity. In this study, we investigated the effect of luteolin in a mouse model of Down syndrome. Ts65Dn mice, which...
8.
Zhou W, Zhang X, Cai Y, Sun W, Li H
Acta Pharmacol Sin
. 2018 Oct;
40(5):608-619.
PMID: 30315252
Tamoxifen (TMX) is an antiestrogen drug that is used in the treatment and prevention of all stages of estrogen-dependent breast cancer. Adverse effects of TMX include hepatotoxicity. In this study,...
9.
Wu L, Zhang Y, Ye M, Shen F, Liu W, Hu H, et al.
Exp Ther Med
. 2017 Jun;
13(6):3529-3534.
PMID: 28587437
Rapid growth of residual tumors can occur as a result of their recurrence and progression. The present study aimed to investigate the expression of hypoxia inducible factor-2 subunit α (HIF-2α),...
10.
Li X, Wu L, Li S, Zhou W, Wang M, Zuo G, et al.
Int J Mol Med
. 2016 Apr;
37(6):1465-74.
PMID: 27082928
FcγRIIIa (CD16) is a low-affinity Fc receptor of IgG. As the idio-binding receptor of IgG Fc, it plays an important role in the antibody-dependent cellular cytotoxicity of natural killer cells....